BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22528084)

  • 1. Quasielastic light scattering study of amyloid β-protein fibrillogenesis.
    Lomakin A; Teplow DB
    Methods Mol Biol; 2012; 849():69-83. PubMed ID: 22528084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quasielastic light scattering study of amyloid beta-protein fibril formation.
    Lomakin A; Teplow DB
    Protein Pept Lett; 2006; 13(3):247-54. PubMed ID: 16515452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring protein assembly using quasielastic light scattering spectroscopy.
    Lomakin A; Benedek GB; Teplow DB
    Methods Enzymol; 1999; 309():429-59. PubMed ID: 10507039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quasielastic light scattering for protein assembly studies.
    Lomakin A; Teplow DB; Benedek GB
    Methods Mol Biol; 2005; 299():153-74. PubMed ID: 15980600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic theory of fibrillogenesis of amyloid beta-protein.
    Lomakin A; Teplow DB; Kirschner DA; Benedek GB
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):7942-7. PubMed ID: 9223292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entrapment of Aβ(1-40) peptide in unstructured aggregates.
    Corsale C; Carrotta R; Mangione MR; Vilasi S; Provenzano A; Cavallaro G; Bulone D; San Biagio PL
    J Phys Condens Matter; 2012 Jun; 24(24):244103. PubMed ID: 22595421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.
    Chen K; Maley J; Yu PH
    J Neurochem; 2006 Dec; 99(5):1413-24. PubMed ID: 17074066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of dynamic light scattering and brownian microscopy to characterize protein aggregation.
    Li Y; Lubchenko V; Vekilov PG
    Rev Sci Instrum; 2011 May; 82(5):053106. PubMed ID: 21639491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.
    Walsh DM; Lomakin A; Benedek GB; Condron MM; Teplow DB
    J Biol Chem; 1997 Aug; 272(35):22364-72. PubMed ID: 9268388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the viscoelasticity of Alzheimer's Abeta42 peptide oligomers a general property of protein oligomers related to their toxicity?
    Saraiva AM; Pereira MC; Brezesinski G
    Langmuir; 2010 Jul; 26(14):12060-7. PubMed ID: 20515050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR reveals two-step association of Congo Red to amyloid β in low-molecular-weight aggregates.
    Pedersen MØ; Mikkelsen K; Behrens MA; Pedersen JS; Enghild JJ; Skrydstrup T; Malmendal A; Nielsen NC
    J Phys Chem B; 2010 Dec; 114(48):16003-10. PubMed ID: 21077638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein L-isoaspartyl O-methyltransferase inhibits amyloid beta fibrillogenesis in vitro.
    Jung G; Ryu J; Heo J; Lee SJ; Cho JY; Hong S
    Pharmazie; 2011 Jul; 66(7):529-34. PubMed ID: 21812329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resonance light scattering as a powerful tool for sensitive detection of β-amyloid peptide by gold nanoparticle probes.
    Wang C; Liu D; Wang Z
    Chem Commun (Camb); 2011 Sep; 47(33):9339-41. PubMed ID: 21766107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical analyses of synthetic amyloid-beta(1-42) aggregates before and after covalent cross-linking. Implications for deducing the structure of endogenous amyloid-beta oligomers.
    Moore BD; Rangachari V; Tay WM; Milkovic NM; Rosenberry TL
    Biochemistry; 2009 Dec; 48(49):11796-806. PubMed ID: 19916493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of end-capping on the self-assembly of model amyloid peptide fragments.
    Castelletto V; Hamley IW; Cenker Ç; Olsson U; Adamcik J; Mezzenga R; Miravet JF; Escuder B; Rodríguez-Llansola F
    J Phys Chem B; 2011 Mar; 115(9):2107-16. PubMed ID: 21309578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
    Kirkitadze MD; Condron MM; Teplow DB
    J Mol Biol; 2001 Oct; 312(5):1103-19. PubMed ID: 11580253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD measurements of β-amyloid (1-40) and (1-42) in the condensed phase.
    Harada T; Kuroda R
    Biopolymers; 2011 Feb; 95(2):127-34. PubMed ID: 20872872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What can light scattering spectroscopy do for membrane-active peptide studies?
    Domingues MM; Santiago PS; Castanho MA; Santos NC
    J Pept Sci; 2008 Apr; 14(4):394-400. PubMed ID: 18189339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
    El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
    FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.